Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome — Stella

Home/Complex Regional Pain Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Complex Regional Pain Syndrome trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Stanford University, Palo Alto, California

Key details

Sponsor

Stanford University

Enrollment target

~120 participants

Started

June 2015

Primary completion

July 2027

Age range

18 Years – 70 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.